- Home
- ALNY vs ADSK Comparison
ALNY vs ADSK Comparison
Compare ALNY & ADSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- ADSK
- Stock Information
- Founded
- ALNY 2002
- ADSK 1982
- Country
- ALNY United States
- ADSK United States
- Employees
- ALNY N/A
- ADSK N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- ADSK Computer Software: Prepackaged Software
- Sector
- ALNY Health Care
- ADSK Technology
- Exchange
- ALNY Nasdaq
- ADSK Nasdaq
- Market Cap
- ALNY 59.6B
- ADSK 63.8B
- IPO Year
- ALNY 2004
- ADSK N/A
- Fundamental
- Price
- ALNY $450.56
- ADSK $324.56
- Analyst Decision
- ALNY Strong Buy
- ADSK Buy
- Analyst Count
- ALNY 29
- ADSK 25
- Target Price
- ALNY $435.04
- ADSK $354.28
- AVG Volume (30 Days)
- ALNY 1.1M
- ADSK 1.7M
- Earning Date
- ALNY 10-30-2025
- ADSK 08-28-2025
- Dividend Yield
- ALNY N/A
- ADSK N/A
- EPS Growth
- ALNY N/A
- ADSK N/A
- EPS
- ALNY N/A
- ADSK 4.81
- Revenue
- ALNY $2,461,963,000.00
- ADSK $6,605,000,000.00
- Revenue This Year
- ALNY $58.79
- ADSK $15.98
- Revenue Next Year
- ALNY $39.75
- ADSK $11.12
- P/E Ratio
- ALNY N/A
- ADSK $66.45
- Revenue Growth
- ALNY 5.01
- ADSK 13.78
- 52 Week Low
- ALNY $205.87
- ADSK $232.67
- 52 Week High
- ALNY $484.21
- ADSK $329.09
- Technical
- Relative Strength Index (RSI)
- ALNY 53.89
- ADSK 64.57
- Support Level
- ALNY $454.51
- ADSK $316.17
- Resistance Level
- ALNY $467.28
- ADSK $326.50
- Average True Range (ATR)
- ALNY 12.99
- ADSK 6.49
- MACD
- ALNY -4.42
- ADSK 0.42
- Stochastic Oscillator
- ALNY 21.20
- ADSK 79.25
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About ADSK Autodesk Inc.
Founded in 1982, Autodesk is an application software company that serves industries in architecture, engineering, and construction; product design and manufacturing; and media and entertainment. Autodesk software enables design, modeling, and rendering needs of these industries. The company has over 4 million paid subscribers across 180 countries.